Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis.
Ontology highlight
ABSTRACT: Bacterial vaginosis (BV) is a common vaginal disorder characterized by the decrease of lactobacilli and overgrowth of Gardnerella vaginalis and resident anaerobic vaginal bacteria. In the present work, the effects of rifaximin vaginal tablets on vaginal microbiota and metabolome of women affected by BV were investigated by combining quantitative PCR and a metabolomic approach based on (1)H nuclear magnetic resonance. To highlight the general trends of the bacterial communities and metabolomic profiles in response to the antibiotic/placebo therapy, a multivariate statistical strategy was set up based on the trajectories traced by vaginal samples in a principal component analysis space. Our data demonstrated the efficacy of rifaximin in restoring a health-like condition in terms of both bact
SUBMITTER: Laghi L
PROVIDER: S-EPMC4068465 | biostudies-literature | 2014 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA